Illumina

-$5.26 (-1.07%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Illumina and other ETFs, options, and stocks.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions.

CEO
Francis A. deSouza
Employees
7,800
Headquarters
San Diego, California
Founded
1998

ILMN Key Statistics

Market Cap
70.99B
Price-Earnings Ratio
113.74
Dividend Yield
—
Average Volume
586.35K
High Today
$490.36
Low Today
$481.15
Open Price
$490.36
Volume
522.00K
52 Week High
$555.77
52 Week Low
$260.42

ILMN News

ReutersJul 22

Illumina deal for Grail could hurt innovation, EU warns

The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake BRUSSELS, July 22 (Reuters) - U.S.
ReutersJul 22

EU antitrust regulators to investigate Illumina, Grail deal

FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California BRUSSELS (Reuters) - EU antitrust regulators opened on Thurs

ILMN Earnings

$0.00
$0.63
$1.26
$1.89
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure